Multicenter comparative evaluation of six commercial systems and the National Committee for Clinical Laboratory Standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species

Journal of Clinical Microbiology

Volumn 40, Issue 8, 2002, Pages 2953-2958

  Morace, Giulia ^a   Amato, G ^a   Bistoni, F ^a   Fadda, G ^a   Marone, P ^a   Montagna, M T ^a   Oliveri, S ^a   Polonelli, L ^a   Rigoli, R ^a   Mancuso, I ^a   La Face, S ^a   Masucci, L ^a   Romano, L ^a   Napoli, C ^a   Tato D ^a   Buscema, M G ^a   Belli, C M C ^a   Piccirillo, M M ^a   Conti, S ^a   Covan, S ^a   Fanti, F ^a   Cavanna, C ^a   D'Alo F ^a   Pitzurra, L ^a   more..

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DOSE RESPONSE; EVALUATION; FUNGUS ISOLATION; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FLUCONAZOLE; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 0036702214     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.8.2953-2958.2002     Document Type: Article

References (18)

1. Arthington-Skaggs, B. A., M. Motley, D. W. Warnock, and C. J. Morrison. 2000. Comparative evaluation of PASCO and National Committee for Clinical Laboratory Standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts. J. Clin. Microbiol. 38:2254-2260.
2. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
3. Cormican, M. G., and M. A. Pfaller. 1996. Standardization of antifungal susceptibility testing, J. Antimicrob. Chemother. 38:561-578.
4. Davey, K. G., A. D. Holmes, E. M. Johnson, A. Szekely, and D. W. Warnock. 1998. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J. Clin. Microbiol. 36:926-930.
5. Davey, K. G., A. Szekely, E. M. Johnson, and D. W. Warnock. 1998. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans. J. Antimicrob. Chemother. 42:439-444.
6. Mers, J., M. Petron, J. Bille, D. Ellis, D. Gibbs, and the Global Antifungal Surveillance Group. 2000. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 36:213-223.
7. National Committee for Clinical Laboratory Standards. 1997. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Perea, S., J. L. Lopez-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
9. Pfaller, M. A., S. A. Messer, S. J. Hollis, A. Espinel-Ingroff, M. A. Ghannoum, H. Plavan, S. B. Killian, and C. C. Knapp. 1998. Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifumgal susceptibility panel. Diagn. Microbiol. Infect. Dis. 31:543-547.
10. Pfaller, M. A., S. A. Messer, A. Karlsson, and A. Bolmstrom. 1998. Evaluation of the E-test method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J. Clin. Microbiol. 36:2586-2589.
11. Pfaller, M. A., D. J. Diekema, R. N. Jones, H. S. Sader, A. C. Fluit, R. J. Hollis, S. A. Messer, and the Sentry Participant Group. 2001. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39:3254-3259.
12. Posteraro, B., L. Romano, M. Sanguinetti, L. Masucci, G. Morace, and G. Fadda. 2000. Commercial systems for fluconazole susceptibility testing of yeasts: Comparison with the broth microdilution method. Diagn. Microbiol. Infect. Dis. 38:29-36.
13. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-672.
14. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: Practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.
15. Strahilevitz, J., A. M. Sugar, and D. Engelhard. 2000. Fluconazole in transplant recipients: Options and limitations. Transpl. Infect. Dis. 2:62-71.
16. Vazquez, J. A., G. Peng, J. D. Sobel, L. Steele-Moore, P. Schuman, W. Holloway, and J. D. Neaton for the Terry Beirn Community Programs for Clinical Research on AIDS. 2001. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. Clin. Infect. Dis. 33:1067-1075.
17. Warnock, D. W., E. M. Johnson, and T. R. Rogers. 1998. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. J. Antimicrob. Chemother. 42:321-331.
18. Warren, N. G., and K. C. Hazen. 1999. Candida, Cryptococcus, and other yeasts of medical importance, p. 1184-1199. In P. R. Murray et al. (ed.), Manual of Clinical Microbiology, 7th Ed. ASM Press, Washington, D.C.